Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC) Meeting Abstract
| Authors: | Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S.; Slovin, S. F.; Blinder, V. S.; Comen, E. A.; Danila, D. C.; Hoffman, D. M. J.; Kang, S.; McAndrew, P.; Modi, S.; Morris, M. J.; Rathkopf, D. E.; Sanford, R. A.; Tate, S. C.; Yu, D.; McArthur, H. L. |
| Abstract Title: | Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 117s |
| Language: | English |
| ACCESSION: | WOS:000487345804498 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.2548 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2548 -- Source: Wos |
